Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 127
DOE waives export ban on highly enriched uranium
By
AuntMinnie.com staff writers
The U.S. Department of Energy (DOE) is moving to allow the export of weapons-grade uranium, the same substance used to manufacture medical isotopes, such as molybdenum-99.
January 8, 2020
RadioMedix, Curium file NDA for PET agent
By
AuntMinnie.com staff writers
Biotechnology firm RadioMedix and global nuclear medicine firm Curium have filed a new drug application (NDA) with the U.S. Food and Drug Administration for the firms' PET diagnostic radiopharmaceutical copper-64 (Cu-64) DOTATATE.
January 7, 2020
Flortaucipir-PET shows moderate promise for CTE
By
Wayne Forrest
PET imaging with flortaucipir revealed uptake patterns indicative of chronic traumatic encephalopathy (CTE) in a new study published online January 6 in
JAMA Neurology
, but the tau-binding radiotracer is not quite ready to be declared a reliable biomarker for the condition, the authors noted.
January 6, 2020
Navidea claims victories in legal case with former CEO
By
AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is claiming victories in several motions in a legal case pitting the company against its former CEO, Dr. Michael Goldberg.
January 2, 2020
PET shows tau better predicts brain atrophy than amyloid
By
Wayne Forrest
PET scans comparing the location and magnitude of tau protein accumulation have shown that tau better predicts future brain atrophy in patients with Alzheimer's disease compared with amyloid deposition -- and a year or more in advance, according to a study published online January 1 in
Science Translational Medicine
.
January 2, 2020
Feinstein Institute gets FDA approval for PET Parkinson's agent
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has granted approval to the Feinstein Institutes for Medical Research for a new radiopharmaceutical to be used with PET to help diagnose and monitor Parkinson's disease.
January 2, 2020
Zr-89 immuno-PET could help predict cancer therapy outcomes
By
Wayne Forrest
Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the
Journal of Nuclear Medicine
.
December 17, 2019
ITC upholds ruling in Jubilant-Bracco case
By
AuntMinnie.com staff writers
The U.S. International Trade Commission (ITC) has upheld an administrative law judge's ruling that Jubilant DraxImage did not violate unfair competition law by exporting its rubidium elution systems into the U.S., as alleged in a suit from contrast developer Bracco Diagnostics.
December 12, 2019
Japanese partnership targets radiotherapeutics
By
AuntMinnie.com staff writers
Osaka University Graduate School of Medicine has signed a collaborative research agreement with Fuzionaire Diagnostics to develop anticancer radiotherapeutic agents.
December 12, 2019
Can FDG-PET/MRI replace biopsy in breast cancer cases?
By
Wayne Forrest
Although FDG-PET/MRI shows promise for accurate staging of breast cancer, the modality still isn't as accurate as sentinel lymph node biopsy, according to a study presented last week at RSNA 2019 in Chicago.
December 10, 2019
PET and prejudice: Insurance firms' misconceptions
By
Wayne Forrest
Healthcare insurance companies should value PET imaging and its cost-effective contributions to patient outcomes rather than view the modality as too expensive and unworthy of reimbursement, according to an editorial in the December issue of the
Journal of Nuclear Medicine
.
December 9, 2019
PET rules out need for radiotherapy in lymphoma patients
By
Abraham Kim
Most patients with diffuse large B-cell lymphoma who have a clear PET scan can safely skip radiation treatment, according to a study funded by the U.S. National Cancer Institute that was presented December 8 at the 2019 American Society of Hematology conference in Orlando, FL.
December 9, 2019
Previous Page
Page 127 of 614
Next Page